Trials / Enrolling By Invitation
Enrolling By InvitationNCT06833125
The Prophylactic Effect of Garlic Tablets to Prevent Nosocomial Infections in Intensive Care Unit Patients.
- Status
- Enrolling By Invitation
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 62 (estimated)
- Sponsor
- Alexandria University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to learn if garlic tablets works to prevent nosocomial infections in hospitalized patients in ICU. The main questions it aims to answer are: Does garlic tablets administration lower the occurence of nosocomial infections in hospitalized patients in ICU?
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Garlic powder standardized to allicin | The intervention is the administration of garlic tablets (Tomex plus 300 mg) two tablets twice daily (which contains 5.4 mg allicin the active ingredient with anibacterial effect) for 6 days just after ICU admission |
Timeline
- Start date
- 2025-03-01
- Primary completion
- 2026-03-01
- Completion
- 2026-04-01
- First posted
- 2025-02-18
- Last updated
- 2025-10-07
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06833125. Inclusion in this directory is not an endorsement.